The main reason of this poor agreement is that in vitro tests reflect only the interaction of the inhibitors (e.g., peptides) with ACE, and in vivo tests account for many other possible physiological factors involved in the manifestation of hypertension [20]. Here, ACE is linked to Hypertension.